Gene Expression Profiling on the Molecular Action of Danshen-Gegen Formula in a Randomized Placebo-Controlled Trial of Postmenopausal Women with Hypercholesterolemia
Figure 1
(a) Percentage changes from baseline in IMT at 6-month and 12-month DG or placebo treatment, ; (b) IMT of subjects at baseline, 6-month, and 12-month DG or placebo treatment (in mm).
